Fizikem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 02-07-2024
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.19 Cr
as on 02-07-2024
- Revenue -6.95%
(FY 2023)
- Profit 74.96%
(FY 2023)
- Ebitda 4.61%
(FY 2023)
- Net Worth 9.29%
(FY 2023)
- Total Assets 7.62%
(FY 2023)
About Fizikem Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹8.19 Cr.
Rajeswari Chakka and Chenna Chakka serve as directors at the Company.
- CIN/LLPIN
U24230AP1997PTC026848
- Company No.
026848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Vijayawada, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Fizikem Laboratories Private Limited offer?
Fizikem Laboratories Private Limited offers a wide range of products and services, including Fitness Supplements, Herbal Fitness Supplements, Ointment, Ayurvedic Medicine, Common Disease Medicines, Pharmaceutical Medicine, Herbal Powder, Amla Powder, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic.
Who are the key members and board of directors at Fizikem Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chenna Chakka  | Managing Director | 09-Apr-1997 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeswari Chakka | Director | 09-Aug-2012 | Current |
Financial Performance of Fizikem Laboratories.
Fizikem Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.95% decrease. The company also saw a substantial improvement in profitability, with a 74.96% increase in profit. The company's net worth moved up by a moderate rise of 9.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fizikem Laboratories?
In 2023, Fizikem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 30 Nov 2023 | ₹1.80 M | Open |
City Union Bank Limited Creation Date: 30 Nov 2021 | ₹2.50 Cr | Open |
Others Creation Date: 11 Jun 2020 | ₹8.37 M | Open |
How Many Employees Work at Fizikem Laboratories?
Fizikem Laboratories has a workforce of 34 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fizikem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fizikem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
